Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man

C. Barbieri; M. Parodi; S. Bruno; F. Bertassi; D. Benaglia; P. Moser; R. Meroni; A. Dubini

doi:10.1007/BF00546704

Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man

C. Barbieri, M. Parodi, S. Bruno, F. Bertassi, D. Benaglia, P. Moser, R. Meroni, A. Dubini

Istituto Clinico Humanitas

Research output: Contribution to journal › Article

Abstract

The neuroendocrinological effects of acute oral administration of 20 mg zetidoline, a new antipsychotic drug with antidopaminergic properties, were evaluated in 8 healthy volunteers, by a double-blind, crossover comparison with placebo. Zetidoline significantly increased serum prolactin (p

Original language	English
Pages (from-to)	29-32
Number of pages	4
Journal	European Journal of Clinical Pharmacology
Volume	26
Issue number	1
DOIs	https://doi.org/10.1007/BF00546704
Publication status	Published - Jan 1984

Keywords

aldosterone
dopamine
healthy volunteers
pharmacodynamic effects
prolactin
zetidoline

ASJC Scopus subject areas

Pharmacology, Toxicology and Pharmaceutics(all)
Pharmacology (medical)

Access to Document

10.1007/BF00546704

Fingerprint Dive into the research topics of 'Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man'. Together they form a unique fingerprint.

Cite this

Barbieri, C., Parodi, M., Bruno, S., Bertassi, F., Benaglia, D., Moser, P., Meroni, R., & Dubini, A. (1984). Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man. European Journal of Clinical Pharmacology, 26(1), 29-32. https://doi.org/10.1007/BF00546704

@article{000de2c271c049e4a3f097e481c62fb0,

title = "Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man",

abstract = "The neuroendocrinological effects of acute oral administration of 20 mg zetidoline, a new antipsychotic drug with antidopaminergic properties, were evaluated in 8 healthy volunteers, by a double-blind, crossover comparison with placebo. Zetidoline significantly increased serum prolactin (p",

keywords = "aldosterone, dopamine, healthy volunteers, pharmacodynamic effects, prolactin, zetidoline",

author = "C. Barbieri and M. Parodi and S. Bruno and F. Bertassi and D. Benaglia and P. Moser and R. Meroni and A. Dubini",

year = "1984",

month = jan,

doi = "10.1007/BF00546704",

language = "English",

volume = "26",

pages = "29--32",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man

AU - Barbieri, C.

AU - Parodi, M.

AU - Bruno, S.

AU - Bertassi, F.

AU - Benaglia, D.

AU - Moser, P.

AU - Meroni, R.

AU - Dubini, A.

PY - 1984/1

Y1 - 1984/1

N2 - The neuroendocrinological effects of acute oral administration of 20 mg zetidoline, a new antipsychotic drug with antidopaminergic properties, were evaluated in 8 healthy volunteers, by a double-blind, crossover comparison with placebo. Zetidoline significantly increased serum prolactin (p

AB - The neuroendocrinological effects of acute oral administration of 20 mg zetidoline, a new antipsychotic drug with antidopaminergic properties, were evaluated in 8 healthy volunteers, by a double-blind, crossover comparison with placebo. Zetidoline significantly increased serum prolactin (p

KW - aldosterone

KW - dopamine

KW - healthy volunteers

KW - pharmacodynamic effects

KW - prolactin

KW - zetidoline

UR - http://www.scopus.com/inward/record.url?scp=0021347516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021347516&partnerID=8YFLogxK

U2 - 10.1007/BF00546704

DO - 10.1007/BF00546704

M3 - Article

C2 - 6143669

AN - SCOPUS:0021347516

VL - 26

SP - 29

EP - 32

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 1

ER -